Proopiomelanocortin Deficiency Treatment Market: How Is...

added blog Health

2026-07-02 10:36:25 -

Proopiomelanocortin Deficiency Treatment Market: How Is Melanocortin-4 Receptor Agonism Redefining Monogenic Obesity Therapeutics?

Proopiomelanocortin deficiency — the ultra-rare monogenic obesity disorder caused by loss-of-function mutations in the POMC gene resulting in early-onset severe obesity, hyperphagia, adrenal insufficiency, and hypopigmentation from absent melanocortin peptide production — creating the most genetically defined segment in rare metabolic disease therapeutics, with the...

0 Comments 0 Shares 8 Views 0 Reviews